#Relapse

CancerAustralian News

Chemotherapy could lead to pediatric leukemia relapse

Washington [US], July 26 (ANI): A new study has found that a group of chemotherapy drugs can result in mutations that may trigger the relapse of blood cancer in children. Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the US, Germany and China have shown how chemotherapy drugs called thiopurines can lead to mutations that set patients up for relapse.
Picture for Chemotherapy could lead to pediatric leukemia relapse
Cancermegadoctornews.com

Chemotherapy Can Induce Mutations That Lead to Pediatric Leukemia Relapse

Newswise — Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the U.S., Germany and China have shown how chemotherapy drugs called thiopurines can lead to mutations that set patients up for relapse. The work appears today in the journal Nature Cancer.
Picture for Chemotherapy Can Induce Mutations That Lead to Pediatric Leukemia Relapse
Healthjagsreport.com

3 Key Aspects of a Successful Relapse Prevention Plan

Stopping using drugs or alcohol when you’re an addict will be one of the hardest things you ever accomplish. Sadly, once you get clean, you’re not out of the woods. You then need to avoid suffering from a relapse. No matter how sure you are that you’ll never go back...
Picture for 3 Key Aspects of a Successful Relapse Prevention Plan
TRENDING TOPICS
Cancerbbcgossip.com

Chemotherapy can induce mutations that lead to pediatric leukemia relapse

Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the U.S., Germany and China have shown how chemotherapy drugs called thiopurines can lead to mutations that set patients up for relapse. The work appears today in the journal Nature Cancer.
Diseases & Treatmentstargetedonc.com

Exploring a Time-to-Relapse Analysis for Rituximab and Transplant in MCL

Peter A. Riedell, MD, discusses the clinical implication of using frontline high-dose rituximab-based therapy and autologous hematopoietic cell transplantation in patients with mantle cell lymphoma in an analysis of time to relapse. Peter A. Riedell, MD, an assistant professor of medicine at the University of Chicago Medicine, discusses the clinical...
CancerMedicalXpress

Chemotherapy can induce mutations that lead to pediatric leukemia relapse

Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the U.S., Germany and China have shown how chemotherapy drugs called thiopurines can lead to mutations that set patients up for relapse. The work appears today in the journal Nature Cancer.
Cancertargetedonc.com

Case Presentation: A 76-Year-Old Man with Relapsed Diffuse Large B-Cell Lymphoma

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma. Laurie Sehn, MD: I’m Laurie Sehn from BC Cancer in Vancouver, Canada. Today I’ll be presenting a case of a patient with relapsed/refractory diffuse large B-cell lymphoma [DLBCL]. This patient is very similar to many patients I see in my own clinic. It’s a 76-year-old man who presented with progressive fatigue, enlarged lymph nodes in his neck and groin, pruritus, and a decreased appetite. He had several comorbidities, including prediabetes, medically controlled hypertension, BPH [benign prostatic hyperplasia], and osteoporosis. On examination, he was found to have palpable cervical and inguinal lymphadenopathy, as well as splenomegaly. Overall, his ECOG performance status was 2.
Musicmxdwn.com

Cave In Sign to Relapse Records and Have New a New Album Coming in 2022

Cave In has signed to Relapse Records and will release a new full-length album in 2022. “Cave In and Relapse have been on each other’s radar since the early days, when we’d visit Philly on a regular basis to play shows,” the band stated in a press release. “They’ve witnessed our wild trajectory as a band firsthand, and having that historical connection with such a powerfully eclectic label is really something special. Massive thanks to everyone at Relapse for honoring our catalog, while fueling the incentive to create new music and continue onward.”
Musicdistortedsoundmag.com

Cave In sign to Relapse Records

For over two decades, the Massachusetts-based metalcore/post-hardcore band have worked and toiled in the heavy music scene to become one of the most respected and revered names out there, and now, the band have signed to Relapse Records. The band will release a brand new album in 2022, their first...
Musictheprp.com

Cave In Sign With Relapse, Digitally Re-Release Back Catalog

Cave In have signed a new deal with Relapse Records and are readying a new full-length album for a 2022 release through the label. Sweetening the pot is the news that Relapse have also re-released the majority of the band’s entire catalog digitally, with the likes of cult classics like “Until Your Heart Stops“, “Jupiter” and more finally widely available to stream.
Musiclambgoat.com

Cave In sign with Relapse Records, prepare new album

Massachusetts rock and metal veterans Cave In have officially signed a deal with Relapse Records. The group will release a new full-length album in 2022. In conjunction with the signing, Cave In have re-released most of their digital catalog, including studio albums, compilations, and various live/demo offerings. Cave In comment:...
YOU MAY ALSO LIKE